ASCO 2026 Poster

This scientific conference poster is for CLIO-8221, an antibody-drug conjugate. It was presented by Callio Therapeutics at the American Society of Clinical Oncology (ASCO) annual meeting in 2026. The challenge with any scientific poster is to present all the technical information as smoothly and effectively as possible, within the limited space, without compromising scientific accuracy.